7917 Stock Overview
Provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
ZACROS Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,245.00 |
| 52 Week High | JP¥4,635.00 |
| 52 Week Low | JP¥3,580.00 |
| Beta | 0.59 |
| 11 Month Change | -5.35% |
| 3 Month Change | 10.69% |
| 1 Year Change | 12.01% |
| 33 Year Change | -12.11% |
| 5 Year Change | 15.35% |
| Change since IPO | 107.53% |
Recent News & Updates
Shareholder Returns
| 7917 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 1.1% | 0.04% | 1.1% |
| 1Y | 12.0% | 10.2% | 12.3% |
Return vs Industry: 7917 exceeded the JP Chemicals industry which returned 10.2% over the past year.
Return vs Market: 7917 matched the JP Market which returned 12.3% over the past year.
Price Volatility
| 7917 volatility | |
|---|---|
| 7917 Average Weekly Movement | 4.2% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in JP Market | 10.1% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 7917 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7917's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 2,664 | Taku Shimoda | www.zacros.co.jp |
ZACROS Corporation provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; MediTect IV Bag, an infusion bags; and Total Thrombus formation Analysis System, a flow chamber system.
ZACROS Corporation Fundamentals Summary
| 7917 fundamental statistics | |
|---|---|
| Market cap | JP¥78.92b |
| Earnings (TTM) | JP¥5.00b |
| Revenue (TTM) | JP¥142.73b |
15.8x
P/E Ratio0.6x
P/S RatioIs 7917 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7917 income statement (TTM) | |
|---|---|
| Revenue | JP¥142.73b |
| Cost of Revenue | JP¥110.74b |
| Gross Profit | JP¥31.99b |
| Other Expenses | JP¥26.98b |
| Earnings | JP¥5.00b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 06, 2025
| Earnings per share (EPS) | 269.16 |
| Gross Margin | 22.41% |
| Net Profit Margin | 3.51% |
| Debt/Equity Ratio | 1.5% |
How did 7917 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield31%
Payout RatioDoes 7917 pay a reliable dividends?
See 7917 dividend history and benchmarks| ZACROS dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Nov 27 2024 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 24 days |
Does 7917 pay a reliable dividends?
See 7917 dividend history and benchmarks